Annals of Internal Medicine

Together by Renee, the all-in-one AI health assistant, improves care for aging Americans with the new Together Companion personal chatbot

Retrieved on: 
Wednesday, March 20, 2024
Software, Men, General Health, Telemedicine, Virtual Medicine, Consumer, Mental Health, Apps, Applications, Technology, Artificial Intelligence, Health Technology, Women, Seniors, Health, Internal medicine, Diabetes, Patient, National Council, Mental health, History, Arthritis, Nausea, Pharmacy, Annals of Internal Medicine, Multimedia, Ageing, Medical device

The Together Companion helps users stay on track toward following their care plans and achieving better health.

Key Points: 
  • The Together Companion helps users stay on track toward following their care plans and achieving better health.
  • 10 in the wellness and personal care category on Fast Company’s 2024 Most Innovative Companies list.
  • For medical appointments, the Together Companion allows users to upload written care plans and record actual in-appointment verbal instructions.
  • The Together Companion provides accurate, timely, contextual and highly personalized answers, and can even proactively follow up with patients regarding their care.

Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related Therapeutics

Retrieved on: 
Friday, October 13, 2023
Mount Sinai, Icahn School of Medicine at Mount Sinai, Contract research organization, Internal medicine, MS, Abstract, Research, VARSITY, The New England Journal of Medicine, Crohn's and Colitis Canada, Therapy, IBD, Safety, University, Inflammatory bowel disease, Annals of Internal Medicine, JAMA, Inflammatory Bowel Diseases, Publication, United States Army Medical Research and Development Command, Dean, Patient, Pharmaceutical industry, MD, Nature, Medicine, Lancet

LONDON, ON, Oct. 13, 2023 /PRNewswire/ - Alimentiv Inc. ("Alimentiv"), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of new scientific advisors to its scientific advisory board.

Key Points: 
  • LONDON, ON, Oct. 13, 2023 /PRNewswire/ - Alimentiv Inc. ("Alimentiv"), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of new scientific advisors to its scientific advisory board.
  • The advisors are internationally recognized experts in designing and conducting clinical research in Inflammatory Bowel Disease.
  • Their contributions to the field have been essential in progressing the development of novel therapies in IBD and improving patient outcomes.
  • He holds the Crohn's Colitis Canada Endowed Research Chair in Inflammatory Bowel Disease and is an executive member of the IOIBD.

Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related Therapeutics

Retrieved on: 
Friday, October 13, 2023
Mount Sinai, Icahn School of Medicine at Mount Sinai, Contract research organization, Internal medicine, MS, Abstract, Research, VARSITY, The New England Journal of Medicine, Crohn's and Colitis Canada, Therapy, IBD, Safety, University, Inflammatory bowel disease, Annals of Internal Medicine, JAMA, Inflammatory Bowel Diseases, Publication, United States Army Medical Research and Development Command, Dean, Patient, Pharmaceutical industry, MD, Nature, Medicine, Lancet

LONDON, ON, Oct. 13, 2023 /PRNewswire/ -- Alimentiv Inc. ("Alimentiv"), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of new scientific advisors to its scientific advisory board.

Key Points: 
  • LONDON, ON, Oct. 13, 2023 /PRNewswire/ -- Alimentiv Inc. ("Alimentiv"), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of new scientific advisors to its scientific advisory board.
  • The advisors are internationally recognized experts in designing and conducting clinical research in Inflammatory Bowel Disease.
  • Their contributions to the field have been essential in progressing the development of novel therapies in IBD and improving patient outcomes.
  • He holds the Crohn's Colitis Canada Endowed Research Chair in Inflammatory Bowel Disease and is an executive member of the IOIBD.

What Is the Impact of Predictive AI in the Health Care Setting? Findings underscore the need to track individuals affected by machine learning predictions.

Retrieved on: 
Monday, October 9, 2023
Nursing care plan, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, Internal medicine, Doctor of Philosophy, Beth Israel Deaconess Medical Center, Machine learning, Death, D3M, Sepsis, Urology, MPH, Roger Hawkins (drummer), Mortality, University, Annals of Internal Medicine, Artificial intelligence, Department of Medicine – University of Pamplona, Kidney, Use, Data-driven, Associate, Learning, Patient, Management, Nursing, MD, RN, Medicine

NEW YORK, Oct. 9, 2023 /PRNewswire-PRWeb/ -- Models built on machine learning in health care can be victims of their own success, according to researchers at the Icahn School of Medicine and the University of Michigan.

Key Points: 
  • Their study assessed the impact of implementing predictive models on the subsequent performance of those and other models.
  • Their study assessed the impact of implementing predictive models on the subsequent performance of those and other models.
  • "These findings are equally applicable outside of health care settings and extend to predictive models in general.
  • The paper is titled "Implications of the Use of Artificial Intelligence Predictive Models in Health Care Settings: A Simulation Study."

Sanguina Raises $2.8M in Series A Funding to Drive Innovation in Home-Based Testing and Wellness Management

Retrieved on: 
Tuesday, July 25, 2023
Health Technology, Technology, Apps, Applications, Other Consumer, General Health, Women, Medical Devices, Men, Artificial Intelligence, Baby, Maternity, Clinical Trials, Family, Biotechnology, Consumer, Health, Mobile, Wireless, Emory University, Dehydration, JAMA, Woman, Georgia Institute of Technology College of Design, Multimedia, Biomarker, Annals of Internal Medicine, Doctor of Philosophy, Aspirin, CDC, Child, American Medical Association, History of the Georgia Institute of Technology, Journal, MD, Anemia, Korea Disease Control and Prevention Agency, Internal medicine, Invention, Artificial intelligence, Conditional sentence, FDA, Nursing, Medical device

Sanguina, a leading biotech company focused on providing rapid home-based testing and management solutions, announced today the successful completion of its $2.8m Series A funding round.

Key Points: 
  • Sanguina, a leading biotech company focused on providing rapid home-based testing and management solutions, announced today the successful completion of its $2.8m Series A funding round.
  • The funding will be used to accelerate the development and expansion of Sanguina's innovative blood health management digital and at-home-based platforms.
  • With advancements in home testing and artificial intelligence, the management of anemia and other chronic conditions is moving towards preventive and personalized medicine.
  • With the successful launch of anemia management through the AnemoCheck app and point-of-care test, Sanguina has taken a major stride towards revolutionizing home-based testing and personalized disease management.

BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement

Retrieved on: 
Thursday, July 13, 2023
Unit, CSE, Lysergic acid diethylamide, Physician, Membrane protein, DSM-IV codes, Annals of Internal Medicine, American College of Physicians, MDD, Patient, Offering, Internal medicine, Neuro, American College, ACP, Major depressive disorder, Pharmaceutical industry

We believe that our compound, BETR-001, has the potential to overcome the hurdles faced by psychedelics, making it potentially a treatment for a broader and more inclusive range of patients.

Key Points: 
  • We believe that our compound, BETR-001, has the potential to overcome the hurdles faced by psychedelics, making it potentially a treatment for a broader and more inclusive range of patients.
  • BETR-001 is a non-hallucinogenic derivative of lysergic acid diethylamide (“LSD”) and covered by BetterLife’s pending patents.
  • Based on its neuro-receptor activity profile in preclinical studies, we believe that BetterLife’s BETR-001 has significant therapeutic potential in various neuro-psychiatric disorders.
  • The Units sold pursuant to the Offering will be subject to a four month hold period pursuant to applicable Canadian securities laws.

Intermittent fasting and calorie counting about equal for weight loss – new study

Retrieved on: 
Tuesday, June 27, 2023
Insulin, Obesity, University, Diet, Body composition, Method, Glucose, Weight loss, Eating, Nutrient, Research, University of Illinois Chicago School of Law, Annals of Internal Medicine, Chicago, Waist, Metabolism, Functional analytic psychotherapy, Internal medicine, Time, Ageing, Fasting, Human, Foodservice, Dietary supplement, Fast food

The traditional approach to weight loss is to count calories and try to reduce the number consumed each day.

Key Points: 
  • The traditional approach to weight loss is to count calories and try to reduce the number consumed each day.
  • Intermittent fasting – and the popular version known as time-restricted eating – could be a simpler option for people wanting to achieve a healthy weight.
  • But is intermittent fasting any better than calorie counting for losing weight?
  • The diets were then adjusted to help maintain this weight loss over the next six months.
  • The researchers hypothesised that participants focusing on reducing the number of hours they ate would achieve and maintain weight loss better than participants focusing on counting calories.
  • These findings support previous studies that have found similar weight loss when comparing time-restricted eating and other popular versions of intermittent fasting (such as the 5:2 diet), to daily calorie restriction.
  • The new study shows that time-restricted eating can lead to weight loss without explicit instruction to reduce calorie intake.

Substantial counselling

    • However, one important aspect of this study that makes it difficult to conclude that these interventions alone are enough to help people lose weight is the fact that participants in both dietary intervention groups received a lot of counselling during the study.
    • Interestingly, a recent study found that time-restricted eating without additional support did not lead to weight loss after three months.
    • There were also substantial differences in weight loss between individual participants on each diet.

Together is the first app to use generative AI to make cumbersome healthcare tasks ‘magically easy’

Retrieved on: 
Tuesday, June 20, 2023
Apps, Applications, Technology, Mobile, Wireless, Health Technology, Telemedicine, Virtual Medicine, Software, Practice Management, Health, Artificial Intelligence, Blood pressure, IPhone, Experian, Google Play, Respiratory rate, Writing, Agency for Healthcare Research and Quality, Calendar, Ageing, Annals of Internal Medicine, Android, Multimedia, Quality, Ensuring Patient Access and Effective Drug Enforcement Act, Centers for Disease Control and Prevention, App Store (iOS/iPadOS), Annals, Patient, Agency, Internal medicine, Frustration, Apple, Conditional sentence, Heart rate, Health literacy, Caregiver, Medical device, Nursing, Health insurance

“As a practicing physician, every day I see patients and caregivers overwhelmed by follow-up steps, care plans and medications.

Key Points: 
  • “As a practicing physician, every day I see patients and caregivers overwhelmed by follow-up steps, care plans and medications.
  • Together makes otherwise cumbersome healthcare tasks magically easy, so people follow my care plans and actually achieve better outcomes," said Together by Renee co-founder and Chief Strategy Officer Dr. Renee Dua.
  • "In healthcare, the biggest impact on the most people comes from solving the most mundane problems," said Together by Renee co-founder and CEO Nick Desai.
  • “The 80 million Americans with more than two chronic conditions — myself included — consume 92% of the U.S. healthcare budget.

Flo's reproductive health survey reveals stark knowledge gaps amongst UK women

Retrieved on: 
Thursday, May 11, 2023
Online, Vagina, Science, Environmental Research, US Census Bureau International Data Base, Pregnancy, Reiko True, MBBS, STI, Spread, COVID-19, Health literacy, Health, Taboo, Market Research Society, Premenstrual syndrome, ChatGPT, Woman, OnePoll, Research, American Community Survey, Annals of Internal Medicine, Masturbation, ESOMAR, United States Census Bureau, MRS, Public health, Breaking Point, Canadian International Council, Berkman, Internal medicine, Systematic review, BMJ, Biology, United Kingdom, Knowledge, Artificial intelligence, International Journal of Environmental Research and Public Health, Ageing, Health services research, NHS, News, Social media, Universal health care, Birth control, Nursing, Online shopping, Hospital, Flo, CINT

LONDON, May 11, 2023 /PRNewswire/ -- Flo Health, the most popular women's health app globally with 50 million monthly active users, has released the findings of a nationwide survey of women aged 18–55, highlighting a staggering degree of misinformation and prominent gaps in the knowledge women have about their own bodies.

Key Points: 
  • Flo's nationwide survey on the state of health literacy shows that 56% of UK women rely on generic advice from search engines for menstrual health information.
  • 72% of women never double-check the health information they get on social media, while nearly one in five (18%) women aged 18–24 go to social media for information around menstrual health.
  • Flo Health's 2023 UK Reproductive Health survey of 2,000 UK women aged 18–66 was commissioned by Flo Health and conducted by market research company OnePoll, in accordance with the Market Research Society's code of conduct.
  • Flo Health's 2023 US Reproductive Health survey was conducted in January 2023 among 2,010 online adult women ages 18–55 via Cint.

American College of Physicians announces initiative to address firearm injury and to speak with patients to keep them safe

Retrieved on: 
Thursday, April 27, 2023
Gun violence in the United States, Violence, Senior, Internal medicine, Public policy, Erickson, Policy, Research, Risk, Annals of Internal Medicine, MACP, Sale, Firearm, Organization, Death, Patient, Physician, SAN, Wound, City, American College, Health, United States Senate Committee on Homeland Security and Governmental Affairs, American College of Physicians, ACP, Injury, Nursing, Telescopic sight

SAN DIEGO, April 27, 2023 /PRNewswire/ -- The American College of Physicians (ACP) today announced a new initiative to help internal medicine physicians address firearm injury and violence as a public health issue and to provide strategies to help keep patients and their loved ones safe.

Key Points: 
  • SAN DIEGO, April 27, 2023 /PRNewswire/ -- The American College of Physicians (ACP) today announced a new initiative to help internal medicine physicians address firearm injury and violence as a public health issue and to provide strategies to help keep patients and their loved ones safe.
  • The American College of Physicians (ACP) today announced a new initiative to help internal medicine physicians address firearm injury and violence as a public health issue and to provide strategies to help keep patients and their loved ones safe.
  • The initiative announced today includes the launch of new online resources for physicians and a one-page guide for speaking with patients about firearm injury, along with a video that provides strategies and tips to have those conversations.
  • The guidance about speaking with patients follows a previous call in the Annals of Internal Medicine, asking health care professionals to pledge to speak with their patients about firearm injury when risk factors are present.